Image 1_Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review of studies before and during the COVID-19 pandemic.jpg

Image 1_Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review of studies before and during the COVID-19 pandemic.jpg

Background<p>Postural Orthostatic Tachycardia Syndrome (POTS) is a complex form of dysautonomia that presents with abnormal autonomic reflexes upon standing, leading to symptoms such as lightheadedness, tachycardia, fatigue, and cognitive impairment. The COVID-19 pandemic has brought renewed a...

Full description

Saved in:
Bibliographic Details
Main Author: Benjamin C. Pierson (20562776) (author)
Other Authors: Kyle Apilado (20562779) (author), M. Alaric Franzos (20562782) (author), Rhonda Allard (20562785) (author), James D. Mancuso (4031354) (author), David Tribble (10949648) (author), David Saunders (221160) (author), Tracey Perez Koehlmoos (14305985) (author)
Published: 2025
Subjects:
Neurology and Neuromuscular Diseases
long COVID
PASC
POTS
dysautonomia
treatment
oral medications
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items